XML 20 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Income - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Product revenues $ 1,456,124 $ 1,469,076 $ 1,204,656
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Cost of sales $ 1,089,693 $ 1,117,452 $ 931,006
Gross margin 366,431 351,624 273,650
Operating expenses:      
Net research and development expenses 88,697 94,358 85,722
Selling, general and administrative expenses 155,108 155,579 132,693
Restructuring expenses, net 13,110 4,739 637
Impairment of intangible assets and property and equipment 2,501   6,291
Impairment of goodwill   19,509  
Total operating expenses 259,416 274,185 225,343
Operating income 107,015 77,439 48,307
Interest expense, net (15,300) (14,641) (4,294)
Foreign currency gain (loss) 9,599 (5,918) (6,778)
Other income (loss) 951 (1,926) 1,147
Earnings before income tax 102,265 54,954 38,382
Income tax expense 37,318 14,611 13,941
Net income $ 64,947 $ 40,343 $ 24,441
Basic earnings per share $ 2.08 $ 1.23 $ 0.74
Diluted earnings per share $ 2.06 $ 1.22 $ 0.73
Weighted average number of shares – basic 31,293,113 32,778,055 33,126,202
Weighted average number of shares – diluted 31,476,486 33,066,917 33,503,154